SCHEMBL1016803

SCHEMBL1016803

CC1CCCC2CN(C(=O)CN3CCc4cc(-n5ccc(C(F)(F)F)n5)ccc4C3)CCN12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.35
POLB P06746 1/20 0.35
ALDH1A1 P00352 3/20 0.35
S1PR1 P21453 2/20 0.35
MGLL Q99685 1/20 0.35
RORC P51449 1/20 0.34
PKM P14618 2/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HRH3 Q9Y5N1 2/20 0.32
CCR1 P32246 3/20 0.32
GRM2 Q14416 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
TSHR P16473 1/20 0.32
KMT2A Q03164 1/20 0.32
XIAP P98170 1/20 0.32
BIRC2 Q13490 1/20 0.32
CHEK1 O14757 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12707095 1.00 GAA (0.35) GAAPOLBALDH1A1S1PR1MGLL
SCHEMBL1018314 0.92 POLB (0.34) GAAPOLBALDH1A1S1PR1MGLL
SCHEMBL12707107 0.92 POLB (0.34) GAAPOLBALDH1A1S1PR1MGLL
SCHEMBL1016845 0.87 POLB (0.39) GAAPOLBALDH1A1S1PR1NPC1
SCHEMBL1603598 0.87 TMEM97 (0.39) GAAPOLBALDH1A1MGLLPKM
SCHEMBL1014842 0.85 PRMT5 (0.40) GAAALDH1A1PKMMAPTHSD17B10
SCHEMBL12707078 0.85 PRMT5 (0.40) GAAALDH1A1PKMMAPTHSD17B10
SCHEMBL12707063 0.80 XIAP (0.41) GAAALDH1A1PKMHSD17B10KDM4E
SCHEMBL1017280 0.80 XIAP (0.41) GAAALDH1A1PKMHSD17B10KDM4E
SCHEMBL1020289 0.79 KDM2B (0.39) GAAALDH1A1PKMHSD17B10HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
EP-1998620-B1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES NEUROGEN CORP (US) 2011-01-12 EP disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues HRH3, HRH4, HRH1 GAA 2016/4885POLB 3403/4885ALDH1A1 1229/4885
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 GAA 2016/4885POLB 3403/4885ALDH1A1 1229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.